Company news

China Animal Husbandry Industry Co., Ltd. Class A (SSE:600195) news

China Animal Husbandry Industry Co., Ltd. Class A news releases on 6ix. Latest, Sep 18, 2026: "China Animal Husbandry Industry Co., Ltd."Announcement…

View China Animal Husbandry Industry Co., Ltd. Class A →

Press releases & updates

"China Animal Husbandry Industry Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing

September 17, 2026

"China Animal Husbandry Industry Co., Ltd."Announcement on Obtaining New Veterinary Drug Registration Certificate by Controlled Subsidiary

August 26, 2026

"China Animal Husbandry Industry Co., Ltd."Announcement on Progress of Participation in Public Bidding for Acquisition of Equity Interests in Controlled Subsidiaries of China Nuclear Uranium Co., Ltd.

August 17, 2026

"China Animal Husbandry Industry Co., Ltd."Announcement on Obtaining the Approval Document for Veterinary Drugs Containing Multivalent Foot-and-Mouth Disease Vaccine (SAT 1)

July 21, 2026

"China Animal Husbandry Industry Co., Ltd."Announcement on Implementation of Dividend Distribution for 2025

June 30, 2026

Announcement on Resolutions of the 5th Extraordinary Meeting of the 9th Board of Directors in 2026

June 4, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

May 15, 2026

Announcement on Attending 2025 Annual and Q1 2026 Collective Performance Briefing of Listed Company Controlled by China National Agricultural Development Group Co., Ltd.

May 7, 2026

Announcement on Resignation of Chairman and Election of New Chairman and Other Matters

April 29, 2026

2025 Annual Report

April 23, 2026

Announcement on Obtaining New Veterinary Drug Registration Certificate

March 25, 2026

Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026

March 20, 2026

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

March 4, 2026

Announcement on Participation in Public Delisting Acquisition of Equity in Holding Subsidiary of China Nuclear Uranium Co., Ltd.

March 3, 2026

Announcement on Resolutions of the 2nd Extraordinary Meeting of the 9th Board of Directors in 2026

February 12, 2026

Announcement on Changing Signatory Certified Public Accountant

February 3, 2026

Announcement on Resolutions of the 1st Extraordinary Meeting of the 9th Board of Directors in 2026

January 28, 2026

Announcement on Progress in the Government Expropriation of Partial Idle Assets of the Company and Its Wholly-Owned Subsidiary

January 23, 2026

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

January 12, 2026

Announcement on Resolutions of the 15th Extraordinary Meeting of the 9th Board of Directors in 2025

December 26, 2025

Announcement on Election of Employee Director

December 22, 2025

Announcement on Progress in Waiving Preemptive Right of Equity of Holding Subsidiary

December 16, 2025

Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025

December 1, 2025

Announcement on Convening the Q3 2025 Performance Briefing

November 14, 2025

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

November 13, 2025

Announcement on Resolutions of the 4th Meeting of the 9th Board of Directors

October 27, 2025

Announcement on the Government Expropriation of Partial Idle Assets of the Company and Its Wholly-Owned Subsidiary

September 28, 2025

Announcement on Results of Exercising the Preemptive Right to Participate in the Subscription of Convertible Corporate Bonds Issued by Xiamen Kingdomway Group Co., Ltd. to Non-specific Objects

September 5, 2025

Announcement on Attending Semi-annual Collective Performance Briefing of Listed Company Controlled by China National Agricultural Development Group Co., Ltd. in 2025

August 27, 2025

Announcement on Exercising the Preemptive Right to Participate in the Subscription of Convertible Corporate Bonds Issued by Xiamen Kingdomway Group Co., Ltd. to Non-specific Objects

August 19, 2025

Announcement on Progress in Receiving Relocation Compensation

July 24, 2025

Announcement on Obtaining Clinical Trial Approval for Veterinary Biological Products

July 17, 2025

Announcement on Implementation of Dividend Distribution for 2024

July 1, 2025

Announcement on Resolution of the 8th Extraordinary Meeting of the 9th Board of Directors in 2025

June 13, 2025

Announcement on Resolution of the 1st Extraordinary General Meeting in 2025

June 10, 2025

Announcement on Resignation and Election of Employee Supervisor

June 6, 2025

Announcement on Resolution of the 7th Extraordinary Meeting of the 9th Board of Directors in 2025

May 23, 2025

Announcement on Resolution of the 2024 Annual General Meeting

May 13, 2025

Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing

May 7, 2025

Report for Q1 2025

April 28, 2025

Announcement on Providing Guarantee for the Financing of Holding Subsidiary

April 22, 2025

Announcement on Annual Provision for Credit and Asset Impairment Losses in 2024

April 11, 2025

Announcement on Resolution of the 4th Extraordinary Meeting of the 9th Board of Directors in 2025

March 27, 2025

Announcement on Resolution of the 3rd Extraordinary Meeting of the 9th Board of Directors in 2025

February 26, 2025

Announcement on Expected Decrease in Annual Performance for 2024

January 10, 2025

Announcement on Resolutions of the 1st Extraordinary Meeting of the 9th Board of Directors in 2025

January 9, 2025

Announcement on Resolutions of the 6th Extraordinary General Meeting in 2024

December 27, 2024

Announcement on Resolution of the 26th Extraordinary Meeting of the 8th Board of Directors in 2024

December 9, 2024

Announcement on Resolution of the 1st Extraordinary Meeting of the 8th Board of Supervisors in 2024

December 3, 2024

Announcement on Resolutions of the 5th Extraordinary General Meeting in 2024

December 2, 2024

Older →